Carasent Asa Stock Beta
| CARA Stock | 21.10 0.80 3.94% |
Carasent ASA fundamentals help investors to digest information that contributes to Carasent ASA's financial success or failures. It also enables traders to predict the movement of Carasent Stock. The fundamental analysis module provides a way to measure Carasent ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Carasent ASA stock.
Carasent |
Carasent ASA Company Beta Analysis
Carasent ASA's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Carasent ASA Beta | 1.06 |
Most of Carasent ASA's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carasent ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Carasent ASA has a Beta of 1.057. This is 22.91% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The beta for all Norway stocks is notably lower than that of the firm.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Carasent ASA returns are very sensitive to returns on the market. As the market goes up or down, Carasent ASA is expected to follow.
Carasent Fundamentals
| Return On Equity | 0.0392 | |||
| Return On Asset | 0.0035 | |||
| Profit Margin | 0.26 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 627.64 M | |||
| Shares Outstanding | 79.62 M | |||
| Shares Owned By Insiders | 16.26 % | |||
| Shares Owned By Institutions | 33.30 % | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 8.00 X | |||
| Revenue | 137.12 M | |||
| Gross Profit | 112.9 M | |||
| EBITDA | 27.72 M | |||
| Net Income | (148 K) | |||
| Book Value Per Share | 15.47 X | |||
| Cash Flow From Operations | 32.48 M | |||
| Earnings Per Share | 0.61 X | |||
| Target Price | 37.0 | |||
| Number Of Employees | 153 | |||
| Beta | 1.06 | |||
| Market Capitalization | 1.33 B | |||
| Total Asset | 1.3 B | |||
| Net Asset | 1.3 B |
About Carasent ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Carasent ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Carasent ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Carasent ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Carasent Stock
Carasent ASA financial ratios help investors to determine whether Carasent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carasent with respect to the benefits of owning Carasent ASA security.